Aetna Company Profile (NYSE:AET)

About Aetna

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment's products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS). The Group Insurance segment's products consist of Life Insurance Products, Disability Insurance Products and Long-Term Care Insurance Products. The Large Case Pensions segment manages a range of retirement products, (including pension and annuity products) primarily for tax-qualified pension plans. Its customers include employer groups, individuals, college students, part-time and hourly workers, health plans, healthcare providers (providers), Government-sponsored plans, labor groups and expatriates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Managed Health Care
  • Exchange: NYSE
  • Symbol: AET
  • CUSIP: 00817Y10
Key Metrics:
  • Previous Close: $129.73
  • 50 Day Moving Average: $122.54
  • 200 Day Moving Average: $119.77
  • 52-Week Range: $351,700,000.00 - $104.59
  • Trailing P/E Ratio: 20.12
  • Foreward P/E Ratio: 13.19
  • P/E Growth: 1.06
  • Market Cap: $45.36B
  • Outstanding Shares: 351,700,000
  • Beta: 0.61
  • Net Margins: 3.58%
  • Return on Equity: 16.39%
  • Return on Assets: 4.34%
  • Debt-to-Equity Ratio: 1.06%
  • Current Ratio: 3.13%
  • Quick Ratio: 1.01%
Additional Links:
Companies Related to Aetna:

Analyst Ratings

Consensus Ratings for Aetna (NYSE:AET) (?)
Ratings Breakdown: 6 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $136.71 (6.00% upside)

Analysts' Ratings History for Aetna (NYSE:AET)
DateFirmActionRatingPrice TargetDetails
2/21/2017Cantor FitzgeraldReiterated RatingOverweight$140.00View Rating Details
2/1/2017Jefferies Group LLCBoost Price Target$133.00View Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00View Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00View Rating Details
1/3/2017RBC Capital MarketsReiterated RatingBuy$145.00View Rating Details
12/28/2016ArgusReiterated RatingBuy$130.00 -> $145.00View Rating Details
11/11/2016Credit Suisse GroupUpgradeNeutral -> Outperform$120.00 -> $125.00View Rating Details
11/7/2016Barclays PLCReiterated RatingBuy$142.00View Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00View Rating Details
8/17/2016FBR & CoReiterated RatingHoldView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformView Rating Details
6/14/2016Morgan StanleyReiterated RatingBuyView Rating Details
6/2/2016Wells Fargo & CoReiterated RatingBuyView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyView Rating Details
4/29/2016Royal Bank of CanadaBoost Price TargetOutperform$140.00 -> $144.00View Rating Details
4/8/2016Cleveland ResearchInitiated CoverageNeutral$120.00View Rating Details
4/5/2016Cowen and CompanyReiterated RatingOutperformView Rating Details
2/3/2016BMO Capital MarketsBoost Price TargetOutperform$128.00 -> $129.00View Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00View Rating Details
2/2/2016Oppenheimer Holdings, Inc.Reiterated RatingMarket PerformView Rating Details
10/30/2015J P Morgan Chase & CoLower Price Target$144.00 -> $141.00View Rating Details
8/4/2015Susquehanna Bancshares IncReiterated RatingBuy$135.00View Rating Details
7/30/2015Bank of America CorpUpgradeNeutral -> Buy$132.00View Rating Details
7/7/2015S&P Equity ResearchReiterated RatingStrong-Buy$150.00View Rating Details
6/17/2015Deutsche Bank AGReiterated RatingBuy$122.00 -> $135.00View Rating Details
(Data available from 2/27/2015 forward)


Earnings History for Aetna (NYSE:AET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.59$1.67$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.55$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aetna (NYSE:AET)
Current Year EPS Consensus Estimate: $8.85 EPS
Next Year EPS Consensus Estimate: $9.78 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20169$1.90$2.40$2.22
Q2 20167$2.05$2.23$2.14
Q3 20165$2.01$2.11$2.05
Q4 20165$1.42$1.56$1.48
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.41$2.35
Q3 20174$2.27$2.42$2.33
Q4 20174$1.69$1.81$1.74
Q1 20181$2.66$2.66$2.66
Q2 20181$2.53$2.53$2.53
Q3 20181$2.51$2.51$2.51
Q4 20181$1.88$1.88$1.88
(Data provided by Zacks Investment Research)


Current Dividend Information for Aetna (NYSE:AET)
Annual Dividend:$1.00
Dividend Yield:0.78%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:15.67% (Based on Trailing 12 Months of Earnings)
11.30% (Based on Current Year Consensus EPS Estimate)
10.22% (Based on Next Year Consensus EPS Estimate)

Dividend History for Aetna (NYSE:AET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Aetna (NYSE:AET)
Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 88.40%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Aetna (NYSE:AET)
News IconCompany Shares of Aetna Inc. (AET) Rally 2.95% - Highland Mirror (NYSE:AET) - February 27 at 6:06 AM
News IconAetna Pharmacy Management - Umd Pharmacy - Cf Services Pharmacy - 8,331 Completed ORDERS Today! (NYSE:AET) - February 26 at 3:20 PM
News IconKings Pharmacy Nyc - Aetna Pharmacy Management - Umd Pharmacy - 3,611 Completed ORDERS Today! (NYSE:AET) - February 26 at 3:20 PM
News IconAetna Specialty Pharmacy Phone Number - Xl Pharmacy - Nova Pharmacy - 1,287 Completed ORDERS Today! (NYSE:AET) - February 26 at 3:20 PM logo[$$] Health Insurers Hope for Nothing (NYSE:AET) - February 26 at 3:20 PM
News IconVeterinary Pharmacies Of America - Aetna Specialty Pharmacy Phone Number - Xl Pharmacy - 8,639 Completed ORDERS Today! (NYSE:AET) - February 26 at 10:35 AM logoDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Aetna ... (NYSE:AET) - February 26 at 10:35 AM logoDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Aetna Inc. To Contact The Firm (NYSE:AET) - February 26 at 10:35 AM
News IconAetna Specialty Pharmacy Phone Number - Xl Pharmacy - Nova Pharmacy - 3,560 Completed ORDERS Today! (NYSE:AET) - February 25 at 8:21 PM
News IconAetna Pharmacy Management - Umd Pharmacy - Cf Services Pharmacy - 3,599 Completed ORDERS Today! (NYSE:AET) - February 25 at 8:21 PM
News IconAetna Inc. (NYSE:AET) EPS Forecast Given As $1.915 - Transcript Daily (NYSE:AET) - February 25 at 3:20 PM
News IconAetna Claims HR Firm Failed to Repay $233,000 in Seed Money (NYSE:AET) - February 24 at 8:21 PM logoHealth Insurers Said To Meet With Trump on Obamacare Replacement (NYSE:AET) - February 24 at 8:21 PM
News IconKings Pharmacy Nyc - Aetna Pharmacy Management - Umd Pharmacy - 2,595 Completed ORDERS Today! (NYSE:AET) - February 24 at 8:21 PM
News IconHealth Insurers, Including Aetna And Cigna, To Meet With Trump On Obamacare Plans (NYSE:AET) - February 24 at 8:21 PM logoAffordable Care Act Replacement Bill Leaked (NYSE:AET) - February 24 at 8:21 PM
News IconAre Analysts Optimistic About Where Aetna Inc. (NYSE:AET) is Heading? - Winfield Review (NYSE:AET) - February 24 at 3:21 PM
News IconWhat Analysts are Predicting For Aetna Inc. (AET), Prologis, Inc. (PLD)? - The USA Commerce (NYSE:AET) - February 24 at 3:21 PM
News IconAetna Specialty Pharmacy Phone Number - Xl Pharmacy - Nova Pharmacy - 3,143 Completed ORDERS Today! (NYSE:AET) - February 24 at 10:25 AM logoOn the eve of Obamacare repeal, more Americans like it than ever (NYSE:AET) - February 24 at 10:25 AM logo5 Things Republicans Want To Change About Obamacare But Might Not Be Able To (NYSE:AET) - February 23 at 8:24 PM
News IconTaking a Look at the Chart for Aetna Inc. (AET) - The USA Commerce (NYSE:AET) - February 23 at 3:23 PM
News IconAetna Inc. (NYSE:AET) Rating Fixed At 2.07 - Stock Observer (NYSE:AET) - February 23 at 3:23 PM
News IconHealth insurer Aetna to spend $3.3 billion buying back stock - (NYSE:AET) - February 23 at 3:23 PM
News IconForward Earnings Estimate of Aetna Inc.(AET) - Highland Mirror (NYSE:AET) - February 23 at 3:23 PM logoAETNA INC /PA/ Financials (NYSE:AET) - February 23 at 3:23 PM logoForm 4 AETNA INC /PA/ For: Feb 17 Filed by: SABATINO THOMAS J JR - (NYSE:AET) - February 22 at 8:24 PM logoAETNA INC /PA/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat (NYSE:AET) - February 22 at 8:24 PM logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:AET) - February 22 at 8:24 PM
News IconAnalyst's Proposition on Tesoro Corporation (TSO), Aetna Inc. (AET) - The USA Commerce (NYSE:AET) - February 22 at 3:22 PM logoAetna initiates accelerated $3.3B share buyback - Seeking Alpha (NYSE:AET) - February 22 at 3:22 PM
News IconHealth insurer Aetna to spend $3.3B buying back stock - (NYSE:AET) - February 22 at 3:22 PM
News IconAetna Inc (NYSE:AET) Strikes Accelerated Share Repurchase Deal With Two Dealers - Stock Market Daily (NYSE:AET) - February 22 at 3:22 PM logoTrump, House Republicans Seek Delay In Healthcare Ruling - Because They're Afraid They'll Win (NYSE:AET) - February 22 at 3:22 PM logoAetna Announces $3.3 Bln Accelerated Share Repurchase - Quick Facts (NYSE:AET) - February 22 at 11:42 AM
News IconTCW Group Inc. Has $3213000 Stake in Aetna Inc (AET) (NYSE:AET) - February 22 at 11:42 AM logoSHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:AET) - February 22 at 11:42 AM logo7:45 am Aetna announces $3.3 bln accelerated share repurchase (NYSE:AET) - February 22 at 11:42 AM logoAetna Announces $3.3 Billion Accelerated Share Repurchase (NYSE:AET) - February 22 at 11:42 AM logoAetna enters $3.3 billion accelerated share buyback program (NYSE:AET) - February 22 at 11:42 AM logoAetna Announces $3.3 Billion Share Repurchase Program (NYSE:AET) - February 22 at 11:42 AM logoHealth insurer Aetna to spend $3.3B buying back stock (NYSE:AET) - February 22 at 11:42 AM logoAET SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 (NYSE:AET) - February 22 at 11:42 AM
News IconHow Does the Chart Look for Aetna Inc. (AET) ? - The USA Commerce (NYSE:AET) - February 21 at 3:38 PM logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc ... - Yahoo Finance (NYSE:AET) - February 21 at 3:38 PM
News IconLookout for Price Target? DENTSPLY SIRONA Inc. (XRAY), Aetna Inc. (AET) - StockNewsJournal (NYSE:AET) - February 21 at 3:38 PM logoHedge Funds Bought Financial, Health Care Stocks in Q4 (NYSE:AET) - February 21 at 3:38 PM
News IconAetna CEO: ObamaCare in a “Death Spiral” - The New American (NYSE:AET) - February 21 at 6:13 AM
News IconAetna Inc (NYSE:AET) Heffx Trading Outlook - Live Trading News (NYSE:AET) - February 21 at 6:13 AM logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aetna Inc. To Contact The Firm Before Lead Plaintiff Deadline (NYSE:AET) - February 21 at 6:13 AM


What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna announced a quarterly dividend on Friday, February 17th. Shareholders of record on Thursday, April 13th will be given a dividend of $0.50 per share on Friday, April 28th. This represents a $2.00 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend is Tuesday, April 11th. This is a positive change from Aetna's previous quarterly dividend of $0.25.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

17 brokerages have issued 1-year price objectives for Aetna's shares. Their forecasts range from $120.00 to $154.00. On average, they expect Aetna's share price to reach $136.71 in the next year.

When will Aetna announce their earnings?

Aetna is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What are analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • Cantor Fitzgerald analysts commented, "We view AET's decision to increase its cash dividend positively. The yield on the shares will now be about 1.6% compared to 0.8% previously. The company announced that it has increased its share repurchase authorization by $4 billion. There remains $1.1 billion outstanding on its current authorization. We view the move to return cash to shareholders positive. Prior to the release, AET and all managed care shares were trading lower today given the news that the Department of Justice will join a whistleblower lawsuit against UnitedHealth Group (UNH) regarding Medicare Advantage reimbursement." (2/14/2017)
  • According to Zacks Investment Research, "Aetna earnings of $1.63 per share, surpassed the Zacks Consensus Estimate of $1.45 and improved 19% year over year. The earnings upside was primarily driven by higher fees and other revenue in Aetna's Health Care segment. Aetna merger with Humana has been blocked by the regulators. Aetna has also been incurring losses in its public exchange business and has been exiting exchanges to avoid losses from this business. Moreover, its membership growth remains under pressure. Increasing medical benefit ratios and cessation of share buyback are also likely to hurt margins. In 2016 the stock of Aetna gained 17.9% lower than the gain of 30% logged by the Zacks categorized Medical Health Maintainence Organisation industry. Nevertheless, Aetna expects long-term growth from its Government business. Cost-reduction initiatives will also add to earnings. A strong balance sheet is another positive." (2/2/2017)

  • Jefferies Group LLC analysts commented, "AET's 4Q EPS was strong (beat by 13%), while initial 2017 guidance was below consensus on both the top and bottom line. As always, favorable prior period development (PPD) is excluded from the outlook and could generate upside. Looking to 2018, earnings growth should accelerate from buyback tailwinds and exiting HIX. We bump up our EPS projections for capital deployment, but remain Hold as the stock seems fairly valued." (2/1/2017)

Who owns Aetna stock?

Aetna's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (6.15%), FMR LLC (2.20%), Glenview Capital Management LLC (1.48%), Janus Capital Management LLC (1.39%), Dimensional Fund Advisors LP (1.12%) and Davis Selected Advisers (1.12%). Company insiders that own Aetna stock include Franklin Barbara Hackman, Gary W Loveman, Jeffrey E Garten, Joseph M Zubretsky, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye, Shawn M Guertin and William James Casazza.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Janus Capital Management LLC, Systematic Financial Management LP, I.G. Investment Management LTD., Deerfield Management Co., Credit Agricole S A, Numeric Investors LLC and Vulcan Value Partners LLC. Company insiders that have sold Aetna stock in the last year include Jeffrey E Garten, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was acquired by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Davis Selected Advisers, Renaissance Technologies LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, AQR Capital Management LLC, Orbimed Advisors LLC, Fred Alger Management Inc. and Asset Management One Co. Ltd..

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Aetna stock cost?

One share of Aetna stock can currently be purchased for approximately $128.97.

Aetna (NYSE:AET) Chart for Monday, February, 27, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Earnings History Chart

Earnings by Quarter for Aetna (NYSE:AET)

Dividend History Chart

Dividend Payments by Quarter for Aetna (NYSE:AET)

Last Updated on 2/27/2017 by Staff